Review article · 2016 · Open access

Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways

Stuart D. Faulkner, M Lee, D Qin, Liz Morrell, Entela Xoxi, Annalisa Sammarco, Silvia Miriam Cammarata, Pierluigi Russo, Luca Pani, Richard Barker

Clinical Pharmacology & Therapeutics, 100(6), 730–742 · Published 14 September 2016 · DOI 10.1002/cpt.508

Open PDFView at the publisherCite this paper

In brief

“Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways” is a 2016 review article by Stuart D. Faulkner and 9 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 33 citations as of 19 November 2026. It is open access: the full text is free to read at Oxford University Research Archive (ORA) (University of Oxford).

Citations
33
Most cited in
2018 (5)
Field-weighted impact
0.83
References
34
Authors
10

Abstract

Earlier patient access to beneficial therapeutics that addresses unmet need is one of the main requirements of innovation in global healthcare systems already burdened by unsustainable budgets. "Adaptive pathways" encompass earlier cross-stakeholder engagement, regulatory tools, and iterative evidence generation through the life cycle of the medicinal product. A key enabler of earlier patient access is through more flexible and adaptive payer approaches to pricing and reimbursement that reflect the emerging evidence generated.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Faulkner, S. D., Lee, M., Qin, D., Morrell, L., Xoxi, E., Sammarco, A., Cammarata, S. M., Russo, P., Pani, L., & Barker, R. (2016). Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways. Clinical Pharmacology & Therapeutics, 100(6), 730–742. https://doi.org/10.1002/cpt.508

MLA 9

Faulkner, Stuart D., et al. “Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.” Clinical Pharmacology & Therapeutics, vol. 100, no. 6, 2016, pp. 730–742. https://doi.org/10.1002/cpt.508.

Chicago

Faulkner, Stuart D., M Lee, D Qin, Liz Morrell, Entela Xoxi, Annalisa Sammarco, Silvia Miriam Cammarata, Pierluigi Russo, Luca Pani, and Richard Barker. 2016. “Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.” Clinical Pharmacology & Therapeutics 100 (6): 730–742. https://doi.org/10.1002/cpt.508.

Harvard

Faulkner, S. D. et al. (2016) ‘Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways’, Clinical Pharmacology & Therapeutics, 100(6), pp. 730–742. doi:10.1002/cpt.508.

IEEE

S. D. Faulkner et al., “Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways,” Clinical Pharmacology & Therapeutics, vol. 100, no. 6, pp. 730–742, 2016, doi: 10.1002/cpt.508.

BibTeX

@article{faulkner2016pricing,
  title     = {{Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways}},
  author    = {Faulkner, Stuart D. and Lee, M and Qin, D and Morrell, Liz and Xoxi, Entela and Sammarco, Annalisa and Cammarata, Silvia Miriam and Russo, Pierluigi and Pani, Luca and Barker, Richard},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2016},
  volume    = {100},
  number    = {6},
  pages     = {730--742},
  doi       = {10.1002/cpt.508},
  url       = {https://doi.org/10.1002/cpt.508}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
201711
201855
201955
202055
202122
202255
202311
202555
202633

Its field-weighted citation impact is 0.83: it has been cited 0.83 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy

  • adaptive pathways
  • drug pricing
  • reimbursement
  • patient access
  • unmet medical needs
  • regulatory instruments
  • pharmaceutical innovation
  • health budget

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Faulkner, S. D., Lee, M., Qin, D., Morrell, L., Xoxi, E., Sammarco, A., Cammarata, S. M., Russo, P., Pani, L., & Barker, R. (2016). Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways. Clinical Pharmacology & Therapeutics, 100(6), 730–742. https://doi.org/10.1002/cpt.508

How many times has this paper been cited?

33 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Oxford University Research Archive (ORA) (University of Oxford): sign in and open the PDF from this page.

Who wrote this paper?

Stuart D. Faulkner, M Lee, D Qin, Liz Morrell, Entela Xoxi, Annalisa Sammarco, Silvia Miriam Cammarata, Pierluigi Russo, Luca Pani, Richard Barker.

What is the DOI of this paper?

10.1002/cpt.508, permanently at https://doi.org/10.1002/cpt.508. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.